Lisa C. Van Hoogstraten

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Surveillance patterns in non-muscle-invasive bladder cancer across risk groups: a real-world analysis.

Surveillance patterns in non-muscle-invasive bladder cancer across risk groups: a real-world analysis.

Journal: BJU international

Published: April 23, 2026

The impact of treatment for muscle-invasive bladder cancer on health-related quality of life.

The impact of treatment for muscle-invasive bladder cancer on health-related quality of life.

Journal: BJU international

Published: April 17, 2025

Health-Related Quality of Life in Patients Treated for Nonmetastatic Muscle-Invasive Bladder Cancer: Radical Cystectomy Versus Bladder-Preserving Therapy.

Health-Related Quality of Life in Patients Treated for Nonmetastatic Muscle-Invasive Bladder Cancer: Radical Cystectomy Versus Bladder-Preserving Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: September 20, 2024

Risk of progression in patients with primary T1 high grade non-muscle invasive bladder cancer - a contemporary cohort.

Risk of progression in patients with primary T1 high grade non-muscle invasive bladder cancer - a contemporary cohort.

Journal: European urology oncology

Published: July 22, 2024

Longer time to radical cystectomy in patients treated with neoadjuvant chemotherapy is associated with worse oncological outcomes.

Longer time to radical cystectomy in patients treated with neoadjuvant chemotherapy is associated with worse oncological outcomes.

Journal: Urologic oncology

Published: September 01, 2023

Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?

Minimum Volume Standards: An Incentive To Perform More Radical Cystectomies?

Journal: European urology open science

Published: February 26, 2023

Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.

Disease-Free Survival of Patients With Muscle-Invasive Bladder Cancer Treated With Radical Cystectomy Versus Bladder-Preserving Therapy: A Nationwide Study.

Journal: International journal of radiation oncology, biology, physics

Published: February 21, 2023

Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice.

Global trends in the epidemiology of bladder cancer: challenges for public health and clinical practice.

Journal: Nature reviews. Clinical oncology

Published: February 13, 2023

Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancer.

Journal: World journal of urology

Published: November 30, 2022

Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: A nationwide cohort study.

Chemoradiation for muscle-invasive bladder cancer using 5-fluorouracil versus capecitabine: A nationwide cohort study.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: November 15, 2022

Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.

Validation and reliability of the Dutch version of the EORTC QLQ-BLM30 module for assessing the health-related quality of life of patients with muscle invasive bladder cancer.

Journal: Health and quality of life outcomes

Published: June 23, 2022

The Impact of the COVID-19 Pandemic on Bladder Cancer Care in the Netherlands.

The Impact of the COVID-19 Pandemic on Bladder Cancer Care in the Netherlands.

Journal: Bladder cancer (Amsterdam, Netherlands)

Published: September 15, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026